Vicarious Surgical (RBOT) Non-Current Deffered Revenue (2020 - 2021)
Vicarious Surgical's (RBOT) quarterly Non-Current Deffered Revenue came in at $1.6 million in Q4 2021, up 2712.07% year-over-year from $58000.0 in Q4 2020, and up 11.18% quarter-over-quarter from $1.5 million in Q3 2021.
Powered by 
Analysis
Vicarious Surgical (RBOT) Non-Current Deffered Revenue (2020 - 2021) Analysis & Trends
Vicarious Surgical (RBOT) has reported Non-Current Deffered Revenue for 2 consecutive years, with $1.6 million the latest figure, recorded in Q4 2021.
- On a quarterly basis, Non-Current Deffered Revenue rose 2712.07% year-over-year to $1.6 million in Q4 2021; TTM through Dec 2021 was $1.6 million, a 2712.07% increase from a year earlier, with the FY2021 full-year figure at $1.6 million, up 2712.07% from the prior year.
- Non-Current Deffered Revenue was $1.6 million for Q4 2021 at Vicarious Surgical, up from $1.5 million in the prior quarter.
- Over five years, Non-Current Deffered Revenue peaked at $12.1 million in Q3 2020 and troughed at $58000.0 in Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Deffered Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Vicarious Surgical | 231,626.35 | -14.81 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2021 | 1.63 Mn |
| Sep 30, 2021 | 1.47 Mn |
| Jun 30, 2021 | 12.08 Mn |
| Mar 31, 2021 | 12.08 Mn |
| Dec 31, 2020 | 58,000.00 |
| Sep 30, 2020 | 12.08 Mn |